. Subsequent to this clinical trial, it has
been determined that living skin equivalents do not persist
in the wound for more than a few weeks, so “no take” occurs as is seen with autologous grafts. Other studies have
reported application at variable times, including weekly,
every few weeks, or once only.261 With no comparative
dosing studies published to determine clinical or economic
outcomes, the frequency of application remains at the
discretion of the